Ad is loading...
MENU
VERV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Verve Therapeutics (VERV) Ownership - Who owns Verve Therapeutics?
Profile
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
410.62M
P/E Ratio
N/A
Total Cash
539.92M
Projected Growth
N/A
Total Debt
71.26M
Revenue
24.4M
Risk (Beta)
1.71
Dividend Yield
N/A
Total Cash/Share
6.38
Total Debt/Equity
N/A
Revenue/Share
0.29 USD as % of share price
Fundamentals
VERV
Capitalization
411M
P/E Ratio
N/A
Risk (Beta)
1.71
Dividend Yield
N/A
Total Cash
540M
Total Cash/Share
6.38
Total Debt
71.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.29%
Revenue
24.4M
ROE
N/A
Book Value
509M
P/B Ratio
0.81
Cash Flow
N/A
Earnings
-2.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
85K
Current Ratio
13.05
Current Revenue Per Employee
26921.57
Dividends Per Share - Security
N/A
EBITDA
-219.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-30.87
Shares Held By Institutions
954M
Shares Outstanding - Current
84.7M
Total Liabilities
155M
Total Volume MTD
N/A
Value
1
Gain YTD
-65.208
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com